STX1A and Alzheimer disease: SNAP25 presented with the strongest and most consistent decline in both humans and animals, while STX1A was not significantly changed in either and the frequently used marker SYP showed moderate loss in both analyses.19 Lastly, both systematic reviews confirmed proteins involved in vesicle exocytosis to be most vulnerable to AD pathology.19